- Bactolife and AceBiome, a renowned innovator and market leader in probiotics within Korea recognized for its scientific expertise and trusted brand reputation, are collaborating to combine Helm™ Binding Proteins with AceBiome’s probiotics to launch a groundbreaking product in Korea
- The partnership brings a holistic gut health solution that goes beyond traditional pre- and probiotics, using precision Binding Proteins to gently bind and neutralize the unhealthy metabolites. Together, probiotics feed the good bacteria while Helm™ Binding Proteins safeguards against the unhealthy, creating optimal support for a balanced, thriving gut.
- AceBiome is a strategic partner of Bactolife in the APAC region, marking a significant milestone in market expansion with the Korean launch, followed by prioritized expansion into Southeast Asia as a key growth opportunity in the near term.
- Both companies emphasize their commitment to scientific excellence, ensuring clinical validation and product safety while addressing the growing consumer demand for effective and holistic gut health solutions.
Copenhagen, Kingdom of Denmark – January 26th, 2026
Bactolife, a first-mover in applying Binding Proteins for gut health, is announcing a strategic partnership with AceBiome, a renowned innovator and market leader in probiotics within Korea. The partnership will combine Bactolife’s scientifically validated, gut supporting food ingredient Helm™ Binding Proteins with AceBiome’s trusted probiotic strains to introduce a groundbreaking health supplement designed to support gut health in the Korean market.
Pioneering gut health innovation in APAC
Bactolife’s ingredient brand, Helm™ Binding Proteins, represent a breakthrough in gut health support, offering precision technology to gently bind and neutralize unhealthy metabolites and stabilizing the gut environment to let the healthy microbes work undisturbed. When paired with AceBiome’s research backed probiotics, this partnership delivers a complete solution that supports gut balance, everyday resilience, and natural immunity. Together, they create optimal support for a balanced, thriving gut.
The collaboration supports the initial introduction of Binding Proteins into the Korean market within a science-backed framework. This partnership marks the beginning of Bactolife’s broader efforts to expand across APAC, with Southeast Asia identified as a key growth priority in the near term.
Sebastian Søderberg, CEO of Bactolife, highlights the strategic importance of this partnership: “Partnering with AceBiome in Asia Pacific, a highly reputable and market-leading supplement brand, allows us to pair Helm™ Binding Proteins with a probiotic in a market like Korea, which is at the forefront of probiotic innovation. This collaboration is a significant step toward delivering a thoughtfully designed, research-backed supplement and making targeted, science-driven gut support more accessible.”
Science-backed solutions for accessible gut health
Both companies are built on the principle of thorough scientific validation, ensuring that the new product meets the highest standards of safety and efficacy. The partnership reflects a shared vision to deliver innovative, research-driven solutions that solve consumers’ unmet needs for efficacious and affordable gut health products, addressing the growing demand for effective and holistic approaches to gut health.
Myeong Hee Kim, Founder & CEO of AceBiome, emphasizes the innovation potential of this collaboration: “Bactolife is a science-driven company whose Helm™ Binding Protein ingredient has been recognized by leading global investment institutions. This collaboration provides a meaningful opportunity to explore the development potential of next-generation health ingredients through joint research combining Bactolife’s Binding Proteins and AceBiome’s accumulated microbiome research expertise. AceBiome will continue its research into novel ingredients across new areas while steadily expanding its presence in the global market.”
For further information, please contact:
Bactolife A/S
Linn Anderberg
Digital Marketing
+46 761 88 42 17
www.bactolife.com
Bactolife A/S | Rønnegade 8, 2nd floor | DK-2100 Copenhagen
AceBiome
Mikayla Yoo
Global Marketing & PR
+82-2-6160-5112
https://acebiome.com
Trade Tower #4203, Yeongdong-daero, Gangnam-gu | Seoul 06164, Korea
About Bactolife A/S
Bactolife is a Danish biotechnology company and the maker of Helm™ Binding Proteins, a functional food ingredient offering an animal-free and vegan-friendly approach to deliver neutralization with greater precision, potency, and reliability. As a science-first company, Bactolife’s adheres to the highest scientific standards with published articles in leading journals including Nature, Wiley, and CellPress.
Backed by their cornerstone investors Novo Holdings, Athos, Cross Border Impact Ventures, EIFO (Danish Export and Investment Fund) and the Gates Foundation, Bactolife is now ready for market entry in 2026.
About Binding Proteins
Binding Proteins are discovered from natural camelid immunoglobins and developed to help maintain balance in the gastrointestinal system. These proteins are produced at scale using advanced biomanufacturing processes, ensuring they can be seamlessly incorporated into regular diets and feeds. By combining precision gut microbiome science with accessible food and feed product applications, Binding Proteins represent a transformative approach to gut health.
About AceBiome
AceBiome is a leading Korean microbiome and probiotic company known for its science-driven leadership in weight management and gut health. The company’s proprietary strain Lactobacillus gasseri BNR17®, marketed under the flagship brand BNRThin, was the first probiotic approved by Korea’s Ministry of Food and Drug Safety (MFDS) for body fat reduction. BNR17® won the Ingredient of the Year Award (Weight Management) at the 2018 NutraIngredients USA Awards and is supported by extensive human clinical trials, with over 1,300 citations in SCIE-indexed international scientific publications. Building on its strong probiotic foundation, AceBiome is expanding into healthy aging and holistic wellness, advancing global health through continuous research and clinically validated innovation.
